(NASDAQ: BBLG) Bone Biologics's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 38.96%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 56.88%.
Bone Biologics's earnings in 2025 is -$7,476,046.On average, 1 Wall Street analyst forecast BBLG's earnings for 2025 to be -$1,052,186, with the lowest BBLG earnings forecast at -$1,052,186, and the highest BBLG earnings forecast at -$1,052,186.
In 2026, BBLG is forecast to generate -$943,151 in earnings, with the lowest earnings forecast at -$943,151 and the highest earnings forecast at -$943,151.